No abstract available
Keywords:
blood-brain barrier; cerebrovascular dysfunction; glial cells; neurodegeneration; neuroinflammation.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Neurovascular changes in neuroinflammatory diseases
References
-
-
Bartels T., Schepper D. S., Hong S. (2020). Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases. Science 370, 66–69. 10.1126/science.abb8587
-
DOI
-
PubMed
-
-
McAlpine C. S., Park J., Griciuc A., Kim E., Choi S. H., Iwamoto Y., et al. . (2021). Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease. Nature 595, 701–706. 10.1038/s41586-021-03734-6
-
DOI
-
PMC
-
PubMed
-
-
Michael T., Heneka, Markus P. K., Eicke L. (2014). Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol. 14, 463–477. 10.1038/nri3705
-
DOI
-
PubMed
-
-
Tiedt S., Buchan A. M., Dichgans M., Lizasoain I., Moro M. A., Lo E. H. (2022). The neurovascular unit and systemic biology in stroke - implications for translation and treatment. Nat. Rev. Neurol. 18, 597–612. 10.1038/s41582-022-00703-z
-
DOI
-
PubMed
-
-
Yang H. S., Zhang C., Carlyle B. C., Zhen S. Y., Trombetta B. A., Schultz A. P., et al. . (2022). Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimers Dement. 18, 645–653. 10.1002/alz.12399
-
DOI
-
PMC
-
PubMed